Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,242
Total Claims
$1.1M
Drug Cost
820
Beneficiaries
$1,400
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-1%
Cost per patient vs peers
$1,400 vs $1,411 avg
+32%
Brand preference vs peers
14.0% vs 10.6% avg
Brand vs Generic
Brand: 2,535 claims · $908K
Generic: 15,549 claims · $234K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 181 | $97K |
| Apixaban | 124 | $86K |
| Rivaroxaban | 120 | $84K |
| Dapagliflozin Propanediol | 87 | $83K |
| Sitagliptin Phosphate | 84 | $69K |
| Levothyroxine Sodium | 770 | $47K |
| Empagliflozin | 48 | $46K |
| Linagliptin/Metformin Hcl | 32 | $38K |
| Sitagliptin Phos/Metformin Hcl | 27 | $35K |
| Empaglifloz/Linaglip/Metformin | 34 | $29K |
| Budesonide/Formoterol Fumarate | 71 | $26K |
| Insulin Lispro | 38 | $23K |
| Sitagliptin Phos/Metformin Hcl | 25 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $21K |
| Ticagrelor | 45 | $20K |
Prescribing Profile
Patient Profile
74
Avg Age
64%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data